| Tamela Hamilton, MD | |
|
1000 Ne 10th St, Oklahoma City, OK 73117-1207 | |
| (405) 271-4060 | |
| Not Available |
| Full Name | Tamela Hamilton |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
| Location | 1000 Ne 10th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316580798 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Tamela Hamilton, MD 1000 Ne 10th St, Oklahoma City, OK 73117-1207 Ph: (405) 271-4060 | Tamela Hamilton, MD 1000 Ne 10th St, Oklahoma City, OK 73117-1207 Ph: (405) 271-4060 |
News Archive
Current guidelines that help clinicians decide whether a woman has had a miscarriage are inadequate and not reliable, and following them may lead to the inadvertent termination of wanted pregnancies. This is the conclusion of a series of papers published in the international journal Ultrasound in Obstetrics and Gynecology.
Liver transplantation is currently the only established treatment for patients with end stage liver failure. However, this treatment is limited by the shortage of donors and the conditional integrity and suitability of the available organs. Transplanting donor hepatocytes (liver cells) into the liver as an alternative to liver transplantation also has drawbacks as the rate of survival of primary hepatocytes is limited and often severe complications can result from the transplantation procedure.
The current classification system for kidney complications in patients with lupus is too detailed, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
Plexxikon Inc. today announced encouraging clinical data from a Phase 1 extension study of PLX4032 (RG7204) in metastatic melanoma patients, which expand the results announced from the initial phase of the study. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors.
› Verified 4 days ago
Peyton Edward Osborne, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 5909 N Barnes Ave, 301 N. Harvey, Oklahoma City, OK 73112 Phone: 405-553-3367 | |
Dr. Karen A Heupel, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Federal Aviation Administration, Aam-700 Bldg 13, Oklahoma City, OK 73169 Phone: 405-954-1000 | |
Dr. Stephen L Carpenter, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 6700 S Macarthur Blvd, Cami Building Room B-13, Oklahoma City, OK 73169 Phone: 405-954-3341 Fax: 405-954-3345 | |
Dr. Randel Dean Estep, DO Preventive Medicine Medicare: Medicare Enrolled Practice Location: 4901 W Reno Ave, Ste 500, Oklahoma City, OK 73127 Phone: 405-230-9250 Fax: 405-943-0742 | |
William Dunlop Jones Iv, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 707 Nw 13th St, Oklahoma City, OK 73103 Phone: 405-521-8604 Fax: 405-521-8605 | |
Dr. Dale Gene Claflin, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 921 Ne 23rd St, Oklahoma City, OK 73105 Phone: 405-425-4486 Fax: 405-419-4250 | |
Dr. Myron Mills, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 238 S Quadrum Dr, Oklahoma City, OK 73108 Phone: 405-416-4246 Fax: 405-949-9352 |